PSTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Poseida Therapeutics Inc

Watchlist Manager

Watchlist

Price: 9.5 USD -0.63%

Market Cap: $926m

	Poseida Therapeutics Inc NASDAQ:PSTX	US
B	Brighthouse Financial Inc F:BROC	US
B	British American Tobacco PLC SWB:BMTA	UK
N	Nike Inc XHAM:NKE	US
	Guangdong Songfa Ceramics Co Ltd SSE:603268	CN
S	Secure Energy Services Inc F:SEP	CA
G	GoGold Resources Inc XMUN:GGD	CA
H	Hamborner REIT AG XMUN:HABA	DE
D	De' Longhi SpA XBER:DLN	IT
C	Canadian National Railway Co F:CY2	CA
	P/F Bakkafrost OTC:BKFKF	FO
P	Procter & Gamble Co F:PRG	US

Profitability Summary

Poseida Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-41%

Negative 3Y Average Operating Margin

-135%

Declining Operating Margin

-18% > -41%

Negative Net Margin

-40%

Negative 3Y Average Net Margin

-129%

Declining Net Margin

-19% > -40%

Negative Free Cash Flow Margin

-11%

Negative 3Y Average Free Cash Flow Margin

-63%

Declining Free Cash Flow Margin

-7% > -11%

Negative ROE

-58%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-151%

Declining ROIC

-47% > -106%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.